June 25, 2019 | City of Hope
City of Hope has accelerated its plans for a $1 billion comprehensive cancer campus in Orange County, bringing highly specialized cancer care, clinical trials, precision medicine and early detection to the nation’s sixth most populous county.
PSCA as a novel CAR T target for resistant prostate cancer
August 20, 2019 | City of Hope
In this phase 1 trial, the safety and tolerability of autologous anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T lymphocytes are studied in adult patients with PSCA+ metastatic castration-resistant prostate cancer.
From ‘wilderness’ to ‘paradise’: A Grammy winner's cancer journey
July 9, 2019 | Malcolm Bedell
When prostate cancer comes calling, it doesn’t count how many Grammys you have sitting on your shelf. Prostate cancer will impact about 1 in 9 men in their lifetimes, and in 2018, it came calling for Kuk Harrell.
Bold steps toward a cure: Clinical trials at City of Hope
May 3, 2019 | Abe Rosenberg
City of Hope’s clinical trials program is special because it was built with the same core values as the institution itself: an emphasis on leading-edge medicine, compassionate care, rapid bench-to-bedside research and always putting the patient first.
‘Watch-and-wait’ approach for low-risk prostate cancer not without dangers
March 7, 2019 | Malcolm Bedell
Men diagnosed with “low-risk” prostate cancer are increasingly refusing more aggressive treatment in favor of a watch-and-wait approach. However, determining which patients truly fall into the “low-risk” category can prove more complicated than some tests would make it seem.
How an artist found the beauty in his cancer journey
November 30, 2018 | Dory Benford
Paul Ecke hasn't let a Stage 4 cancer diagnosis slow him down. Thanks to his doctor, Tanya Dorff, M.D., the artist has turned the pain of his diagnosis into beautiful works of art he shares with the world.
Prostate cancer advances help extend a patient's life
September 11, 2018 | Dory Benford
Johnny Lopez's research into the latest prostate cancer treatments, clinical trials, experimental therapies — anything to avoid chemotherapy, and a recommendation from a friend also battling prostate cancer, led him to Tanya Dorff, M.D., and City of Hope.